EUR 13.06
(1.08%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 490.44 Million EUR | -2.99% |
2022 | 505.55 Million EUR | 21.22% |
2021 | 417.05 Million EUR | 14.23% |
2020 | 365.09 Million EUR | 17.91% |
2019 | 309.64 Million EUR | 1.81% |
2018 | 304.15 Million EUR | 35.89% |
2017 | 223.82 Million EUR | -2.78% |
2016 | 230.22 Million EUR | -1.93% |
2015 | 234.75 Million EUR | 17.66% |
2014 | 199.53 Million EUR | -6.99% |
2013 | 214.51 Million EUR | -34.71% |
2012 | 328.53 Million EUR | -23.47% |
2011 | 429.29 Million EUR | 14.23% |
2010 | 375.8 Million EUR | 12.01% |
2009 | 335.5 Million EUR | -6.06% |
2008 | 357.15 Million EUR | 95.21% |
2007 | 182.95 Million EUR | 40.16% |
2006 | 130.53 Million EUR | 32.02% |
2005 | 98.87 Million EUR | -38.43% |
2004 | 160.6 Million EUR | -49.72% |
2003 | 319.4 Million EUR | -11.28% |
2002 | 360 Million EUR | -6.96% |
2001 | 386.93 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 505.87 Million EUR | 0.0% |
2023 FY | 490.44 Million EUR | -2.99% |
2023 Q2 | 523.33 Million EUR | 0.0% |
2023 Q4 | 490.44 Million EUR | 0.0% |
2022 FY | 505.55 Million EUR | 21.22% |
2022 Q2 | 452.8 Million EUR | 0.0% |
2022 Q4 | 505.55 Million EUR | 0.0% |
2021 Q4 | 417.05 Million EUR | 0.0% |
2021 Q2 | 363.73 Million EUR | 0.0% |
2021 FY | 417.05 Million EUR | 14.23% |
2020 Q4 | 365.09 Million EUR | 0.0% |
2020 FY | 365.09 Million EUR | 17.91% |
2020 Q2 | 342.74 Million EUR | 0.0% |
2019 Q2 | 293.74 Million EUR | 0.0% |
2019 FY | 309.64 Million EUR | 1.81% |
2019 Q4 | 309.64 Million EUR | 0.0% |
2018 Q2 | 261.55 Million EUR | 0.0% |
2018 FY | 304.15 Million EUR | 35.89% |
2018 Q4 | 304.15 Million EUR | 0.0% |
2017 Q4 | 223.82 Million EUR | 0.0% |
2017 FY | 223.82 Million EUR | -2.78% |
2017 Q2 | 221.24 Million EUR | 0.0% |
2016 Q2 | 235.43 Million EUR | 0.0% |
2016 FY | 230.22 Million EUR | -1.93% |
2016 Q4 | 230.22 Million EUR | 0.0% |
2015 FY | 234.75 Million EUR | 17.66% |
2015 Q2 | 206.78 Million EUR | 0.0% |
2015 Q4 | 234.75 Million EUR | 0.0% |
2014 FY | 199.53 Million EUR | -6.99% |
2014 Q4 | 199.53 Million EUR | 0.0% |
2014 Q2 | 209.01 Million EUR | 0.0% |
2013 Q2 | 271.43 Million EUR | 0.0% |
2013 Q4 | 214.51 Million EUR | 0.0% |
2013 FY | 214.51 Million EUR | -34.71% |
2012 Q2 | 348.22 Million EUR | 0.0% |
2012 Q4 | 328.53 Million EUR | 0.0% |
2012 FY | 328.53 Million EUR | -23.47% |
2011 Q4 | 429.29 Million EUR | 0.0% |
2011 FY | 429.29 Million EUR | 14.23% |
2011 Q2 | 420.16 Million EUR | 0.0% |
2010 Q2 | 379.11 Million EUR | 0.0% |
2010 FY | 375.8 Million EUR | 12.01% |
2010 Q4 | 375.8 Million EUR | 0.0% |
2009 FY | 335.5 Million EUR | -6.06% |
2009 Q4 | 335.5 Million EUR | 0.0% |
2008 FY | 357.15 Million EUR | 95.21% |
2007 FY | 182.95 Million EUR | 40.16% |
2006 FY | 130.53 Million EUR | 32.02% |
2005 FY | 98.87 Million EUR | -38.43% |
2004 FY | 160.6 Million EUR | -49.72% |
2003 FY | 319.4 Million EUR | -11.28% |
2002 FY | 360 Million EUR | -6.96% |
2001 FY | 386.93 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Affluent Medical SA | 25.15 Million EUR | -1850.006% |
Bluelinea Société Anonyme | 8.86 Million EUR | -5432.572% |
Carmat SA | 96.83 Million EUR | -406.497% |
Diagnostic Medical Systems S.A. | 37.41 Million EUR | -1210.792% |
Euromedis Groupe | 23.66 Million EUR | -1972.276% |
Eurobio Scientific Société anonyme | 141.15 Million EUR | -247.447% |
Ikonisys S.A. | 5.11 Million EUR | -9479.117% |
Implanet S.A. | 10.81 Million EUR | -4436.546% |
Median Technologies SA | 46.22 Million EUR | -960.928% |
SpineGuard SA | 5 Million EUR | -9702.249% |
Theraclion SA | 13.01 Million EUR | -3667.859% |
Euroapi S.A. | 684.7 Million EUR | 28.371% |
Guerbet SA | 646.97 Million EUR | 24.193% |
Koninklijke Philips N.V. | 17.63 Billion EUR | 97.22% |
Sequana Medical NV | 29.56 Million EUR | -1558.806% |